Series B - KalVista Pharmaceuticals - Jul 22, 2015 Funding Round Profile - Cointime

Bitcoin $99,185.30 +1.96%
Ethereum $3,380.64 +7.97%
BNB $629.58 +2.79%
Optimism $2.07 +20.21%
Arbitrum $0.79 +12.51%
Solana $259.83 +8.25%
Polygon $0.46 +5.46%
Cosmos $6.58 +5.64%
Avalanche $36.14 +6.19%

Bitcoin $99,185.30 +1.96%
Ethereum $3,380.64 +7.97%
BNB $629.58 +2.79%
Optimism $2.07 +20.21%
Arbitrum $0.79 +12.51%
Solana $259.83 +8.25%
Polygon $0.46 +5.46%
Cosmos $6.58 +5.64%
Avalanche $36.14 +6.19%

KalVista Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 33M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
RA Capital Management	-	Yes	-	Detail
Longwood Fund	-	-	-	Detail
Novo Holdings	-	-	-	Detail
SV Health Investors	-	-	-	Detail
Venrock	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 23, 2011	Series A	£ 8M	Novo Holdings,SV Health Investors	Detail